Handan Onur

Medicine · Health Sciences

9h-index338citations48works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(14), Breast Cancer Treatment Studies(9), HER2/EGFR in Cancer Research(6), Blood groups and transfusion(6), Advanced Breast Cancer Therapies(5)

Publications48 total

Reversing Death in Lung Cancer: Epigenetic Control Mechanisms Underlying Anastasis
Bursa Uludag University - AVESIS·2025
Reversing Death in Lung Cancer: Epigenetic Control Mechanisms Underlying Anastasis
2025
Vakalarla Kulak Burun Boğaz
2022Open Access
Effects of Adjuvant Chemotherapy on Insulin Resistance in Patients with Early Breast Cancer
Cam and Sakura Medical Journal·2022· 1 citedOpen Access
Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study
European Journal of Breast Health·2018· 10 citedOpen Access
Diagnostic Serum Vitamin D Level is Not a Reliable Prognostic Factor for Resectable Breast Cancer
Future Oncology·2018· 4 cited
Persistent postmastectomy pain syndrome and posttraumatic stress disorder among breast cancer survivors (ORTHUS study): A study of the palliative care working committee of the Turkish Oncology Group (TOG).
Journal of Clinical Oncology·2016
Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG)
Supportive Care in Cancer·2016· 23 cited
Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.
Journal of Clinical Oncology·2015
P276 Effect of tumor hormonal and HER2 status on localization of metastases in recurrent breast cancer
The Breast·2015
The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer.
PubMed·2015· 22 cited
P170 Serum levels of CEA and CA 15-3 in different subtypes of recurrent breast cancer
The Breast·2015Open Access
P279 More prognostic factors in early stage breast cancer
The Breast·2015
P167 Preoperative systemic therapy for locally advanced breast cancer: single center experience
The Breast·2015· 1 citedOpen Access
P278 Effect of HER2 and hormonal status to FDG uptake on PET/CT imaging in recurrent breast cancer
The Breast·2015Open Access
P267 Blood group: is it associated with tumor biology in breast cancer?
The Breast·2015Open Access
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
Meme sağlığı dergisi/Meme sağlığı dergisi·2014· 9 citedOpen Access
Upper reference limits for serum thyroid stimulating hormone levels in Turkish children
Clinical Biochemistry·2014
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience Triple-Negatif Meme Kanserinin Seyri: Türk Onkoloji Grubu Çalişmasi
2014
Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)
Breast Cancer·2013· 6 cited
page 1 of 3Next →

Frequent Co-authors

Hakan Akbulut(28), Fikri İçlı(27), Ahmet Demirkazık(16), Filiz Çay Şenler(14), Bülent Yalçın(13), Dìlek Dìnçol(13), Güngör Utkan(10), Dılşa Mızrak(9), Abdullah Büyükçelik(8), Yüksel Ürün(7), Gül Başaran(7), P. Kubilay(7), Kadri Altundağ(6), Yeşim Eralp(6), Bengi Öztürk(6), Güngör Utkan(5), Pınar Saip(5), Abdurrahman Işıkdoğan(4), Filiz Çay(4), İzzet Doğan(4)